Recombinant Dopamine Receptor D2 (DRD2)Homo sapiens (Human)Recombinant protein

DR-D2; D2DR; D2R

  • Product No.RPA673Hu01
  • Organism SpeciesHomo sapiens (Human)Same name, Different species.
  • SourceProkaryotic expression
  • HostE.coli
  • Endotoxin Level<1.0EU per 1µg (determined by the LAL method)
  • Subcellular Locationn/a
  • Predicted Molecular Mass53.6kDa
  • Accurate Molecular Massn/a(Analysis of differences refer to the manual)
  • Residues & TagsVal200~Ile384 (Accession # P14416) with N-terminal His Tag
  • Buffer FormulationPBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
  • TraitsFreeze-dried powder
  • Purity> 95%
  • Isoelectric Pointn/a
  • ApplicationsSDS-PAGE; WB; ELISA; IP.
  • DownloadInstruction Manual
  • UOM10ug50ug200ug1mg1g
  • FOBUS$ 192US$ 480US$ 960US$ 2880US$ 72000
  • Recombinant Dopamine Receptor D2 (DRD2)Package and Components
  • Recombinant Dopamine Receptor D2 (DRD2)Package and Components
    • RPA673Hu01.jpgSDS-PAGE
    • CertificateISO9001: 2008, ISO13485: 2003 Registered

    SEQUENCE

    USAGE

    Reconstitute in PBS or others.

    STORAGE

    Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

    STABILITY

    The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

    Reference

    • Front Behav NeurosciDistinct patterns of outcome valuation and amygdala-prefrontal cortex synaptic remodeling in adolescence and adulthoodPubMed: 25999830
    • Behavioural Brain ResearchSex differences, learning flexibility, and striatal dopamine D1 and D2 following adolescent drug exposure in ratsPubmed:27091300